Technical Analysis for AVGR - Avinger, Inc.

Grade Last Price % Change Price Change
grade F 1.64 7.89% 0.12
AVGR closed up 7.89 percent on Friday, August 16, 2019, on 21 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AVGR trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 7.89%
NR7 Range Contraction 7.89%
Stochastic Reached Oversold Weakness 7.89%
Wide Bands Range Expansion 7.89%
Down 3 Days in a Row Weakness 7.89%
Down 4 Days in a Row Weakness 7.89%
Oversold Stochastic Weakness 7.89%
Wide Bands Range Expansion 3.14%

Older signals for AVGR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Avinger, Inc., a medical device company, designs, manufactures, and sells image-guided, catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD). It offers Lightbox, an imaging console, which enables the use of lumivascular catheters during PAD procedures; Ocelot, a chronic total occlusion (CTO) crossing catheter, which allows physicians to see the inside of an artery during a CTO crossing procedure; Ocelot PIXL, a lower profile CTO-crossing device for below-the-knee arteries; and Ocelot MVRX, a device which offers a tip design for above-the-knee arteries. The company also provides Wildcat, a catheter that facilitates the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention; and Kittycat 2, a catheter that facilitate the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists directly in the United States and Europe. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Medicine Medical Specialties Clinical Medicine Imaging Medical Imaging Catheters Catheter Interventional Radiology Interventional Cardiology Cordis Peripheral Arterial Disease Percutaneous
Is AVGR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.5
52 Week Low 1.41
Average Volume 330,241
200-Day Moving Average 4.4048
50-Day Moving Average 2.8876
20-Day Moving Average 1.8813
10-Day Moving Average 1.664
Average True Range 0.2516
ADX 38.51
+DI 14.822
-DI 32.4211
Chandelier Exit (Long, 3 ATRs ) 1.9602
Chandelier Exit (Short, 3 ATRs ) 2.1648
Upper Bollinger Band 2.3873
Lower Bollinger Band 1.3753
Percent B (%b) 0.26
BandWidth 53.79259
MACD Line -0.3656
MACD Signal Line -0.4079
MACD Histogram 0.0423
Fundamentals Value
Market Cap 39.21 Million
Num Shares 23.9 Million
EPS -2.46
Price-to-Earnings (P/E) Ratio -0.67
Price-to-Sales 0.50
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.84
Resistance 3 (R3) 1.82 1.73 1.80
Resistance 2 (R2) 1.73 1.68 1.74 1.79
Resistance 1 (R1) 1.69 1.65 1.71 1.71 1.78
Pivot Point 1.60 1.60 1.62 1.61 1.60
Support 1 (S1) 1.56 1.55 1.58 1.58 1.50
Support 2 (S2) 1.47 1.52 1.48 1.49
Support 3 (S3) 1.43 1.47 1.48
Support 4 (S4) 1.45